Healthcare -
Biotechnology - NASDAQ - US
$ 21.98
-1.7 %
$ 16.2 B
Market Cap
-95.57
P/E
SMMT - STOCK-BASED COMPENSATION
Stock-based Compensation SMMT - Summit Therapeutics Inc.
14.1 M
LAST VALUE
22.07%
2 YEAR CAGR
17.79%
5 YEAR CAGR
43.81%
10 YEAR CAGR